Manegold PC - Search Results

1

Platelet-endothelial interaction in tumor angiogenesis and microcirculation.

Manegold PC, Hutter J, Pahernik SA, Messmer K, Dellian M. Manegold PC, et al. Blood. 2003 Mar 1;101(5):1970-6. doi: 10.1182/blood.V101.5.1970. Blood. 2003. PMID: 12584142 Free article.

2

Antiangiogenic therapy with mammalian target of rapamycin inhibitor RAD001 (Everolimus) increases radiosensitivity in solid cancer.

Manegold PC, Paringer C, Kulka U, Krimmel K, Eichhorn ME, Wilkowski R, Jauch KW, Guba M, Bruns CJ. Manegold PC, et al. Clin Cancer Res. 2008 Feb 1;14(3):892-900. doi: 10.1158/1078-0432.CCR-07-0955. Clin Cancer Res. 2008. PMID: 18245553

3

Interleukin-8 is associated with proliferation, migration, angiogenesis and chemosensitivity in vitro and in vivo in colon cancer cell line models.

Ning Y, Manegold PC, Hong YK, Zhang W, Pohl A, Lurje G, Winder T, Yang D, LaBonte MJ, Wilson PM, Ladner RD, Lenz HJ. Ning Y, et al. Among authors: manegold pc. Int J Cancer. 2011 May 1;128(9):2038-49. doi: 10.1002/ijc.25562. Int J Cancer. 2011. PMID: 20648559 Free PMC article.

4

The dual EGFR/HER-2 tyrosine kinase inhibitor lapatinib sensitizes colon and gastric cancer cells to the irinotecan active metabolite SN-38.

LaBonte MJ, Manegold PC, Wilson PM, Fazzone W, Louie SG, Lenz HJ, Ladner RD. LaBonte MJ, et al. Among authors: manegold pc. Int J Cancer. 2009 Dec 15;125(12):2957-69. doi: 10.1002/ijc.24658. Int J Cancer. 2009. PMID: 19536776 Free article.

5

Targeting metastatic colorectal cancer in 2008: a long way from 5-FU.

Pohl A, Zhang W, Ning Y, Manegold PC, Lurje G, Lenz HJ. Pohl A, et al. Among authors: manegold pc. Oncology (Williston Park). 2008 Apr 15;22(4):456-62; discussion 462-3, 467-8, 474 passim. Oncology (Williston Park). 2008. PMID: 18472617 Free article. Review.

6

Pharmacogenomics and -genetics in colorectal cancer.

Pohl A, Lurje G, Manegold PC, Lenz HJ. Pohl A, et al. Among authors: manegold pc. Adv Drug Deliv Rev. 2009 May 20;61(5):375-80. doi: 10.1016/j.addr.2008.10.002. Epub 2008 Dec 3. Adv Drug Deliv Rev. 2009. PMID: 19100300 Review.

7

Thymidylate synthase gene variations: predictive and prognostic markers.

Lurje G, Manegold PC, Ning Y, Pohl A, Zhang W, Lenz HJ. Lurje G, et al. Among authors: manegold pc. Mol Cancer Ther. 2009 May;8(5):1000-7. doi: 10.1158/1535-7163.MCT-08-0219. Epub 2009 Apr 21. Mol Cancer Ther. 2009. PMID: 19383851 Review.

8

A coactivator role of CARM1 in the dysregulation of β-catenin activity in colorectal cancer cell growth and gene expression.

Ou CY, LaBonte MJ, Manegold PC, So AY, Ianculescu I, Gerke DS, Yamamoto KR, Ladner RD, Kahn M, Kim JH, Stallcup MR. Ou CY, et al. Among authors: manegold pc. Mol Cancer Res. 2011 May;9(5):660-70. doi: 10.1158/1541-7786.MCR-10-0223. Epub 2011 Apr 8. Mol Cancer Res. 2011. PMID: 21478268 Free PMC article.

9

Polymorphisms in interleukin 1 beta and interleukin 1 receptor antagonist associated with tumor recurrence in stage II colon cancer.

Lurje G, Hendifar AE, Schultheis AM, Pohl A, Husain H, Yang D, Manegold PC, Ning Y, Zhang W, Lenz HJ. Lurje G, et al. Among authors: manegold pc. Pharmacogenet Genomics. 2009 Feb;19(2):95-102. doi: 10.1097/FPC.0b013e32831a9ad1. Pharmacogenet Genomics. 2009. PMID: 18987561

10

Differentiation Therapy Targeting the β-Catenin/CBP Interaction in Pancreatic Cancer.

Manegold P, Lai KKY, Wu Y, Teo JL, Lenz HJ, Genyk YS, Pandol SJ, Wu K, Lin DP, Chen Y, Nguyen C, Zhao Y, Kahn M. Manegold P, et al. Cancers (Basel). 2018 Mar 29;10(4):95. doi: 10.3390/cancers10040095. Cancers (Basel). 2018. PMID: 29596326 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

18 results

Search Page